Catalyst Wire Dossier Catalyst Wire Dossier

adoptive BCMA CAR-NK cells

BCMA CAR-NK cells · Asclepius Technology Company Group (Suzhou) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for adoptive BCMA CAR-NK cells, covering 2019-05-07 to 2019-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MM [Phase 1, Phase 2]

See pricing